G. Breitenecker

发表

Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival.

G. Gitsch, E. Hanzal, P. Kohlberger, 1992, Anticancer research.

Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.

M. Schindl, G. Oberhuber, P. Birner, 2001, Gynecologic oncology.

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients

G. Heinze, L. Hefler, C. Kainz, 1999, British Journal of Cancer.

Impact of human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer.

M. Schindl, G. Oberhuber, P. Birner, 2001, Cancer letters.

Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.

G. Breitenecker, W. Neunteufel, 1989, Gynecologic Oncology.

Accuracy of Intraoperative Frozen-Section Diagnosis in Stage I Endometrial Adenocarcinoma

E. Kucera, C. Kainz, S. Leodolter, 2000, Gynecologic and Obstetric Investigation.

Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy.

P. Speiser, C. Kainz, A. Obermair, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Mutant p53 in patients with invasive cervical cancer stages IB to IIB.

C. Kainz, G. Sliutz, A. Reinthaller, 1995, Gynecologic oncology.

CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma.

G. Breitenecker, W. Neunteufel, 1989, Cancer letters.

Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.

H. Heinzl, H. Kölbl, C. Kainz, 1996, European journal of cancer.

Infiltrating ductal carcinoma of the breast: extensive intraductal component has no impact on lymph node involvement and survival.

C. Kainz, G. Gitsch, E. Joura, 1995, Anticancer research.

DNA profiles and numeric histogram classifiers in nephrogenic adenoma

M. Susani, H. Wiener, A. Pycha, 2002, Cancer.

Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women.

S. Leodolter, E. Joura, G. Breitenecker, 2000, The Journal of reproductive medicine.

Comparative Evaluation of Seven Cell Collection Devices for Cervical Smears

D. Kieback, G. Gitsch, P. Kohlberger, 1999, Acta Cytologica.

Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas

H. Kölbl, G. Gitsch, E. Hanzal, 2006, Archives of Gynecology and Obstetrics.

Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer.

C. Kainz, G. Gitsch, A. Loesch, 1996, Cancer letters.

CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading

C. Bieglmayer, G. Breitenecker, W. Neunteufel, 2004, Archives of Gynecology and Obstetrics.

Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer

M. Micksche, M. Vetterlein, G. Breitenecker, 1989 .

[Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].

P. Regitnig, F. Moinfar, G. Breitenecker, 2007, Der Pathologe.

Cytopathology in Austria

P. Regitnig, H. Wiener, C. Vutuc, 2004, Cytopathology : official journal of the British Society for Clinical Cytology.

Cervical cancer screening in Austria.

H. Wiener, G. Breitenecker, J. Stani, 2000, European journal of cancer.

KAI1 metastasis suppressor protein in cervical cancer.

M. Schindl, G. Oberhuber, P. Birner, 2002, The American journal of pathology.

Signal-Amplified Colorimetric In Situ Hybridization for Assessment of Human Papillomavirus Infection in Cervical Lesions

M. Schindl, E. Joura, G. Oberhuber, 2001, Modern Pathology.

Diagnosis of cervical intraepithelial neoplasia and human papillomavirus infection: punch biopsy versus cervical smear

A. Reinthaller, G. Gitsch, G. Breitenecker, 2006, Archives of Gynecology and Obstetrics.

Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.

F. Breitenecker, C. Kainz, G. Gitsch, 1997, Gynecologic oncology.

Numerical Chromosomal Aberrations in Borderline, Benign, and Malignant Epithelial Tumors of the Ovary: Correlation With p53 Protein Overexpression and Ki-67

C. Kainz, G. Gitsch, H. Wiener, 1997, The Journal of the Society for Gynecologic Investigation: JSGI.

Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma

E. Tschachler, C. Kainz, G. Sliutz, 1995, Cancer.

p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.

G. Heinze, N. Hacker, G. Gitsch, 1998, Gynecologic oncology.

PREMALIGNANT AND MALIGNANT UTERINE CHANGES IN IMMUNOSUPPRESSED RENAL TRANSPLANT RECIPIENTS

H. Husslein, G. Breitenecker, G. Tatra, 1978, Acta obstetricia et gynecologica Scandinavica.

Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma.

N. Hacker, M. Friedlander, D. Bancher-Todesca, 1998, Gynecologic oncology.

Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer.

M. Schindl, S. Breiteneder-Geleff, S. Schoppmann, 2001, Anticancer research.

Lymphatic microvessel density as a novel prognostic factor in early‐stage invasive cervical cancer

M. Schindl, H. Kowalski, A. Obermair, 2001, International journal of cancer.

Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer.

M. Schindl, H. Kowalski, A. Obermair, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis.

M. Schindl, H. Kowalski, A. Obermair, 2000, Anticancer research.

Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer.

C. Kainz, S. Leodolter, G. Sliutz, 1996, Gynecologic oncology.

[Prognostic significance of morphological parameters in malignant epithelial ovarian tumors].

G. Breitenecker, V. Scheiber, W. Bartl, 1983, Der Pathologe.

Prostatic Tissue in Mature Cystic Teratomas of the Ovary: A Report of Four Cases, Including One with Features of Prostatic Adenocarcinoma, and Cytogenetic Studies

E. Oliva, R. Young, P. Mazal, 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Cryo-Assisted Resection En Bloc, and Cryoablation In Situ, of Primary Breast Cancer Coupled With Intraoperative Ultrasound-Guided Tracer Injection: A Preliminary Clinical Study

G. Breitenecker, Kecheng Xu, Masashi Watanabe, 2018, Technology in cancer research & treatment.

The differential diagnosis of primary peritoneal papillary tumors

G. Gitsch, G. Breitenecker, W. Feigl, 2007, Archives of Gynecology and Obstetrics.

Splice variants of CD44 in human cervical cancer stage IB to IIB.

H. Heinzl, C. Kainz, G. Sliutz, 1995, Gynecologic oncology.

The prognostic value of CD44 isoform expression in endometrial cancer.

A. Kaider, L. Hefler, C. Kainz, 1998, British Journal of Cancer.

Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium.

H. Heinzl, E. Stickeler, C. Kainz, 1997, Gynecologic oncology.

CD-44 is not involved in the metastatic spread of ovarian cancer in vivo.

P. Speiser, C. Kainz, P. Kohlberger, 1995, Anticancer research.

Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.

H. Kölbl, G. Gitsch, G. Breitenecker, 1989, Anticancer research.

[Age distribution of women with cervical intraepithelial neoplasia and invasive cervical cancer. Its importance for the evaluation of the efficacy of cervical cytological screening (author's transl)].

G. Breitenecker, 1978, Wiener klinische Wochenschrift.

Immunohistochemical detection of estrogen and progesterone receptor in human cornea.

K. Kircher, P. Kohlberger, G. Breitenecker, 2000, Maturitas.

Pituitary-gonadal feedback in testicular disorders

J. Holzner, J. Spona, G. Breitenecker, 2005, International Urology and Nephrology.

[Trophoblastic disease. I. Use of immunohistochemistry in the diagnosis of complete hydatidiform moles].

J. Vojtaššák, J. Porubský, G. Breitenecker, 1994, Ceskoslovenska patologie.

Prognostic value of CD44 splice variants in human stage III cervical cancer.

C. Kainz, G. Sliutz, A. Reinthaller, 1995, European journal of cancer.

Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.

M. Schindl, A. Obermair, G. Oberhuber, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection.

C. Kainz, A. Haitel, H. Wiener, 1999, Gynecologic oncology.

Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.

M. Schindl, R. Horvat, P. Birner, 2004, Gynecologic oncology.

Mola invasiva--special form of GTD.

J. Vojtaššák, G. Breitenecker, L. Danihel, 1999, General Physiology and Biophysics.

[Extrauterine choriocarcinoma--a rare form of gestational trophoblastic disease].

J. Porubský, G. Breitenecker, L. Danihel, 1996, Bratislavske lekarske listy.

Investigation of 208 Consecutive Cases of Cervical Cone Biopsies with Regard to Indication, Negative Samples and Quality Control

P. Sevelda, W. Ulrich, G. Breitenecker, 2006, Acta Cytologica.

p53 protein overexpression in early stage endometrial cancer.

A. Kaider, C. Kainz, A. Reinthaller, 1996, Gynecologic oncology.

Leiomyoma of the round ligament in a postmenopausal woman.

C. Kainz, G. Breitenecker, A. Lösch, 1999, Maturitas.

Expression of cytokeratins in granulosa cell tumors and ovarian carcinomas

A. Steiner, G. Gitsch, P. Kohlberger, 2007, Archives of Gynecology and Obstetrics.

Leiomyosarcoma of the vulva. A case report.

E. Joura, G. Breitenecker, A. Lösch, 2001, The Journal of reproductive medicine.

Prognostic significance of tumor angiogenesis in primary fallopian tube cancer.

G. Heinze, G. Gitsch, A. Obermair, 1999, Cancer letters.

Ovarian Activity During Gestation

G. Breitenecker, P. Kemeter, F. Friedrich, 1980 .

Ovulation inhibition with human chorionic gonadotrophin.

H. Salzer, G. Breitenecker, P. Kemeter, 1974, Acta endocrinologica.

Enzyme activity in the fluid of the human ovarian follicle.

G. Breitenecker, F. Friedrich, E. Golob, 1972, Gynecologic investigation.

Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

M. Schindl, A. Obermair, G. Oberhuber, 2000, Cancer research.

Thoughts on the Cytopathologist and Cell Culture

Anshu, Carlos F. Villamil, M. Bibbo, 1999, Acta Cytologica.

Histochemical localization of phosphohydrolases in testes of man and rat

P. Böck, G. Breitenecker, Gerhard Lunglmayr, 2004, Zeitschrift für Anatomie und Entwicklungsgeschichte.

The progesterone content of the fluid and the activity of the steroid-3beta-ol-dehydrogenase within the wall of the ovarian follicles.

H. Salzer, J. Holzner, G. Breitenecker, 1974, Acta endocrinologica.

Contributor Index Volume 43, 1999

Anshu, Carlos F. Villamil, M. Bibbo, 1999, Acta Cytologica.

Morphology of rabbit oviduct after reanostomosis with fibrin glue

G. Breitenecker, P. Riss, R. Spernol, 1984, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[Anastomosis of the vas deferens employing concentrated fibrinogen: an experimental study in rabbits (authors transl)].

G. Breitenecker, G. Lunglmayr, H. Pflüger, 1976, Wiener klinische Wochenschrift.

[Quantitative immunological determination of antithrombin III concentration during normal pregnancy and post partum (author's transl)].

G. Breitenecker, W. Gruber, G. Tatra, 1974, Archiv fur Gynakologie.

Angiogenesis in vulvar intraepithelial neoplasia.

C. Kainz, S. Leodolter, G. Gitsch, 1997, Gynecologic oncology.

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients: 10-year results of a prospective randomised phase III study comparing carboplatin–cisplatin with cyclophosphamide–cisplatin

M. Schemper, A. Kaider, P. Sevelda, 2003 .

The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma

A. Kaider, P. Speiser, C. Kainz, 1998, Cancer.

Original Paper Prognostic Value ofCD44 Splice Variants in Human Stage III Cervical Cancer

C. Kainz, G. Sliutz, A. Reinthaller, 1995 .

Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature.

C. Kainz, A. Reinthaller, E. Joura, 1998, Gynecologic oncology.

Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer

R. Pötter, A. Obermair, P. Birner, 2002, International journal of cancer.

Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone?

E. Kucera, S. Leodolter, G. Sliutz, 2001, European journal of obstetrics, gynecology, and reproductive biology.

The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer.

M. Schindl, G. Oberhuber, P. Birner, 2000, Anticancer research.

[Optimum surgical staging and rational use of radiodiagnostic methods in case of ovarian carcinomas (stages III and IV)].

T. Szepesi, G. Breitenecker, S. Szalay, 1982, Strahlentherapie.

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin.

M. Schemper, A. Kaider, P. Sevelda, 2004, European journal of cancer.

Expression of Hypoxia-inducible Factor 1 a in Epithelial Ovarian Tumors: Its Impact on Prognosis and on Response to Chemotherapy 1

M. Schindl, A. Obermair, G. Oberhuber, 2001 .

Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia.

S. Leodolter, R. Horvat, P. Kohlberger, 2003, Gynecologic oncology.

Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.

A. Kaider, C. Kainz, G. Gitsch, 1996, British Journal of Cancer.

Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison.

F Breitenecker, F. Breitenecker, A. Kaider, 1999, Anticancer research.

Progesterone, oestradiol-17 beta and testosterone levels in the follicular fluid of tertiary follicles and Graafian follicles of human ovaries.

H. Salzer, G. Breitenecker, P. Kemeter, 1974, Acta Endocrinologica.

Further investigations on the maturation and degeneration of human ovarian follicles and their oocytes.

G. Breitenecker, P. Kemeter, F. Friedrich, 1978, Fertility and sterility.

[The significance of clinical and morphological parameters for the prognosis of granulosa cell tumors of the ovaries].

G. Breitenecker, R. Spernol, W. Bartl, 1984, Geburtshilfe und Frauenheilkunde.

CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.

P. Speiser, C. Kainz, G. Sliutz, 1998, British Journal of Cancer.

Radiosurgery in the management of cervical intraepithelial neoplasia.

C. Kainz, G. Sliutz, A. Reinthaller, 1996, The Journal of reproductive medicine.

[The absorption of conjugated oestrogens from the irradiated and non-irradiated vagina (author's transl)].

G. Breitenecker, P. Kemeter, G. Tatra, 1980, Geburtshilfe und Frauenheilkunde.

Cervical cancer: The diagnostic value of rectosonography for the judgement of parametrial invasion in regard of inflammatory stromal reaction

A. Reinthaller, G. Gitsch, J. Deutinger, 1993, British journal of obstetrics and gynaecology.

Cervical neoplasia and human papilloma virus infection in prostitutes.

C. Kainz, A. Reinthaller, G. Gitsch, 1991, Genitourinary medicine.

When applied to facial skin, does estrogen ointment have systemic effects?

C. Kainz, G. Gitsch, G. Breitenecker, 2007, Archives of Gynecology and Obstetrics.

Prognostic value of laminin-5 in serous adenocarcinomas of the ovary.

H. Heinzl, S. Leodolter, A. Obermair, 2002, Anticancer Research.

Small-cell carcinoma of the uterus and the vagina: experience with ten patients

E. Petru, A. Obermair, G. Breitenecker, 2005, Archives of Gynecology and Obstetrics.

Hybrid capture based human papillomavirus typing in cervical screening compared to cytology and histology.

M. Schindl, G. Oberhuber, P. Birner, 2000, Wiener klinische Wochenschrift.

Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.

T. Waldhoer, G. Haidinger, C. Vutuc, 1999, Wiener klinische Wochenschrift.

Fractal analysis: an objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri.

R Sedivy, E Moser, C Windischberger, 1999, Gynecologic oncology.

Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods.

H. Heinzl, C. Kainz, G. Sliutz, 1996, American journal of clinical pathology.

Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study.

D. Kieback, G. Gitsch, E. Joura, 1998 .

Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB.

A Reinthaller, P. Speiser, C. Kainz, 1995, Anticancer research.

Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumors.

H. Kölbl, C. Bieglmayer, G. Breitenecker, 1989, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Immunohistochemistry in stage FIGO III cervical cancer: prognostic value of tumor associated antigens and intermediate filaments.

C. Kainz, G. Gitsch, H. Koelbl, 1992, Anticancer research.

Mutant p53 product in patients with stage III cervical cancer.

C. Kainz, G. Gitsch, E. Joura, 1992, Anticancer research.

Zervixkarzinom-Screening

G. Breitenecker, Prof. Dr. G. Breitenecker, 2009, Der Pathologe.

Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer.

C. Kainz, E. Joura, P. Kohlberger, 1998, British Journal of Cancer.

Quick‐staining urinary cytology and bladder wash image analysis with an integrated risk classification

M. Susani, H. Wiener, G. Schatzl, 1999, Cancer.

Prognostic value of cytokeratins and carcinoembryonic antigen expression in primary surgically treated cervical cancer.

H. Heinzl, C. Kainz, A. Reinthaller, 1994, Anticancer research.